文献检索文档翻译深度研究

邀请有礼套餐&价格历史记录

新学期，新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

不再提醒

插件&应用

Zotero 插件浏览器插件 Mac 客户端 Windows 客户端微信小程序

高级版

套餐订阅购买积分包

AI 工具

文献检索文档翻译深度研究

关于我们

关于 Suppr 公司介绍联系我们用户协议隐私条款

关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究

粤ICP备2023148730 号-1Suppr @ 2025

Metastatic non-small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

作者信息

Novello S, Barlesi F, Califano R, Cufer T, Ekman S, Levra M Giaj, Kerr K, Popat S, Reck M, Senan S, Simo G V, Vansteenkiste J, Peters S

机构信息

Oncology Department, University of Turin, AOU San Luigi-Orbassano, Orbassano, Italy.

Assistance Publique Hôpitaux de Marseille, Multidisciplinary Oncology and Therapeutic Innovations Department, Aix Marseille University, Marseille, France.

出版信息

Ann Oncol. 2016 Sep;27(suppl 5):v1-v27. doi: 10.1093/annonc/mdw326.

DOI:10.1093/annonc/mdw326

Abstract

摘要

相似文献

[1]

Metastatic non-small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

Ann Oncol. 2016-9

[2]

Use of adjuvant chemotherapy (CT) and radiotherapy (RT) in incompletely resected (R1) early stage Non-Small Cell Lung Cancer (NSCLC): a European survey conducted by the European Society for Medical Oncology (ESMO) young oncologists committee.

Lung Cancer. 2014-3-16

[3]

Correction to: "Metastatic non-small cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up".

Ann Oncol. 2019-5

[4]

Non-small-cell lung cancer: ESMO clinical recommendations for diagnosis, treatment and follow-up.

Ann Oncol. 2009-5

[5]

Small-cell lung cancer: ESMO clinical recommendations for diagnosis, treatment and follow-up.

Ann Oncol. 2009-5

[6]

Biliary cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

Ann Oncol. 2016-9

[7]

Oesophageal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

Ann Oncol. 2016-9

[8]

How do lung cancer specialists follow their patients with stage III non-small cell lung cancer (NSCLC) after definitive treatment? A short report.

Eur J Cancer. 2012-5-26

[9]

Real-world treatment patterns and costs in a US Medicare population with metastatic squamous non-small cell lung cancer.

Lung Cancer. 2014-11-8

[10]

Locally recurrent or metastatic breast cancer: ESMO clinical recommendations for diagnosis, treatment and follow-up.

Ann Oncol. 2009-5

引用本文的文献

[1]

Treatment Response and Survival in Thyroid Transcription Factor-1 Negative Non-squamous Non-small Cell Lung Cancer.

Cancer Diagn Progn. 2025-9-1

[2]

Real-World Outcomes of T790M Mutation Testing and Sequential Osimertinib in EGFR-Positive Advanced Non-small Cell Lung Cancer: A Revisited Strategy.

Target Oncol. 2025-9-2

[3]

Cost-effectiveness analysis of penpulimab plus carboplatin-paclitaxel as first-line treatment for metastatic squamous non-small-cell lung cancer in China.

Health Econ Rev. 2025-7-12

[4]

Cost-Effectiveness of Pembrolizumab Monotherapy for High Programmed Death Ligand 1 Advanced or Metastatic Non-small Cell Lung Cancer Depends on Long-Term Survivors.

Clin Drug Investig. 2025-7-9

[5]

Tumor-associated macrophages derived exosomal circPLK1 promotes resistance to EGFR inhibitor osimertinib in non-small cell lung cancer.

Discov Oncol. 2025-7-1

[6]

Efficacy and Safety of Antibody-Drug Conjugates for Lung Cancer Therapy: A Systematic Review of Randomized and Non-Randomized Clinical Trials.

Pharmaceutics. 2025-5-3

[7]

Efficacy of Anlotinib Plus Docetaxel in Advanced NSCLC Previously Treated with Platinum-Based Chemotherapy: A Systematic Review and Meta-Analysis.

Pharmaceuticals (Basel). 2025-4-29

[8]

LAURA Completes the Osimertinib Treatment Jigsaw Puzzle of + NSCLC from Stage IB to IV: Adjuvant Osimertinib Significantly Improves PFS and CNS Progression in Unresectable Stage III -Mutated NSCLC Compared to Placebo (LAURA, NCT03521154).

Lung Cancer (Auckl). 2025-4-25

[9]

Serum and exosome WNT5A levels as biomarkers in non-small cell lung cancer.

Respir Res. 2025-4-13

[10]

Predicting a failure of postoperative thromboprophylaxis in non-small cell lung cancer: A stacking machine learning approach.

PLoS One. 2025-4-1

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

推荐工具

医学文档翻译智能文献检索